Total Payments
$12,916
2024 Payments
$1,275
Companies
65
Transactions
907
Medicare Patients
2,140
Medicare Billing
$136,933
Payment Breakdown by Category
Food & Beverage$12,650 (97.9%)
Education$266.24 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,650 | 900 | 97.9% |
| Education | $266.24 | 7 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,331 | 76 | $0 (2024) |
| PFIZER INC. | $1,131 | 127 | $0 (2024) |
| Novo Nordisk Inc | $908.36 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $867.29 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $852.90 | 62 | $0 (2024) |
| Lilly USA, LLC | $706.41 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $699.13 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $683.33 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $613.17 | 38 | $0 (2024) |
| Astellas Pharma US Inc | $468.00 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,275 | 67 | ABBVIE INC. ($341.27) |
| 2023 | $1,913 | 82 | AbbVie Inc. ($463.60) |
| 2022 | $1,403 | 85 | Boehringer Ingelheim Pharmaceuticals, Inc. ($172.15) |
| 2021 | $1,514 | 91 | AbbVie Inc. ($267.82) |
| 2020 | $1,273 | 93 | Novo Nordisk Inc ($192.59) |
| 2019 | $1,535 | 133 | PFIZER INC. ($247.51) |
| 2018 | $2,009 | 172 | PFIZER INC. ($241.32) |
| 2017 | $1,994 | 184 | PFIZER INC. ($227.86) |
All Payment Transactions
907 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.16 | General |
| 10/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $87.28 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Pulmonology | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.51 | General |
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardio-renal | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 517 | 620 | $84,708 | $41,668 |
| 2022 | 9 | 465 | 536 | $68,041 | $35,745 |
| 2021 | 7 | 373 | 432 | $58,145 | $27,662 |
| 2020 | 15 | 785 | 891 | $73,765 | $31,857 |
Total Patients
2,140
Total Services
2,479
Medicare Billing
$136,933
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 115 | 115 | $26,335 | $14,094 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 113 | $24,447 | $9,538 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 120 | $16,686 | $6,874 | 41.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $5,660 | $4,229 | 74.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 40 | $2,800 | $2,744 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $3,885 | $1,925 | 49.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 40 | $1,760 | $1,173 | 66.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 12 | $1,752 | $491.62 | 28.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $660.00 | $439.95 | 66.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $583.00 | $97.92 | 16.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 28 | $140.00 | $61.60 | 44.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $21,755 | $11,890 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 97 | $19,303 | $7,520 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 92 | $11,776 | $5,265 | 44.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $5,632 | $4,449 | 79.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 43 | 44 | $3,080 | $3,006 | 97.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 100 | 100 | $3,500 | $1,743 | 49.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 45 | $1,980 | $1,255 | 63.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $880.00 | $558.35 | 63.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 27 | $135.00 | $60.00 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 95 | 95 | $21,755 | $12,132 | 55.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 85 | $16,915 | $6,917 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 103 | $13,184 | $4,566 | 34.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 37 | 37 | $2,590 | $2,415 | 93.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 54 | 54 | $1,890 | $960.12 | 50.8% |
About Dr. Peter Christensen, MD
Dr. Peter Christensen, MD is a Family Medicine healthcare provider based in West Jordan, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992737159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Christensen, MD has received a total of $12,916 in payments from pharmaceutical and medical device companies, with $1,275 received in 2024. These payments were reported across 907 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($12,650).
As a Medicare-enrolled provider, Christensen has provided services to 2,140 Medicare beneficiaries, totaling 2,479 services with total Medicare billing of $136,933. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location West Jordan, UT
- Active Since 07/07/2006
- Last Updated 07/17/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992737159
Products in Payments
- VRAYLAR (Drug) $814.73
- JARDIANCE (Drug) $744.39
- ELIQUIS (Drug) $638.29
- XARELTO (Drug) $554.43
- UBRELVY (Drug) $439.88
- Ozempic (Drug) $431.85
- FARXIGA (Drug) $367.06
- SHINGRIX (Biological) $352.62
- TRULICITY (Drug) $285.11
- LATUDA (Drug) $280.32
- JANUVIA (Drug) $275.99
- SYMBICORT (Drug) $268.03
- QULIPTA (Drug) $246.70
- CHANTIX (Drug) $205.04
- TRINTELLIX (Drug) $173.78
- Victoza (Drug) $168.20
- Otezla (Drug) $164.93
- LYRICA (Drug) $161.24
- TOUJEO (Drug) $154.64
- MYRBETRIQ (Drug) $140.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Jordan
Judith Kirstein, M.d, M.D
Family Medicine — Payments: $20,575
Family Medicine $20,575
Dennis Hamp, D. O, D. O
Family Medicine — Payments: $14,286
Family Medicine $14,286
Michael Sanderson, Md, MD
Family Medicine — Payments: $13,770
Family Medicine $13,770
Preston Wilson, D.o, D.O
Family Medicine — Payments: $13,194
Family Medicine $13,194
Brenten Pugh, M.d, M.D
Family Medicine — Payments: $10,976
Family Medicine $10,976
Randall Fillmore, Md, MD
Family Medicine — Payments: $10,920
Family Medicine $10,920